120 related articles for article (PubMed ID: 38936451)
21. Glucagon-Like Peptide-1 Receptor Agonist Attenuates Autophagy to Ameliorate Pulmonary Arterial Hypertension through Drp1/NOX- and Atg-5/Atg-7/Beclin-1/LC3β Pathways.
Wu YC; Wang WT; Lee SS; Kuo YR; Wang YC; Yen SJ; Lee MY; Yeh JL
Int J Mol Sci; 2019 Jul; 20(14):. PubMed ID: 31336911
[TBL] [Abstract][Full Text] [Related]
22. GLP-1 receptor agonist liraglutide protects cardiomyocytes from IL-1β-induced metabolic disturbance and mitochondrial dysfunction.
Zhang L; Tian J; Diao S; Zhang G; Xiao M; Chang D
Chem Biol Interact; 2020 Dec; 332():109252. PubMed ID: 32898504
[TBL] [Abstract][Full Text] [Related]
23. Glucagon-like peptide-1 receptor agonist treatment of high carbohydrate intake-induced metabolic syndrome provides pleiotropic effects on cardiac dysfunction through alleviations in electrical and intracellular Ca
Durak A; Akkus E; Canpolat AG; Tuncay E; Corapcioglu D; Turan B
Clin Exp Pharmacol Physiol; 2022 Jan; 49(1):46-59. PubMed ID: 34519087
[TBL] [Abstract][Full Text] [Related]
24. Val8-glucagon-like peptide-1 protects against Aβ1-40-induced impairment of hippocampal late-phase long-term potentiation and spatial learning in rats.
Wang XH; Li L; Hölscher C; Pan YF; Chen XR; Qi JS
Neuroscience; 2010 Nov; 170(4):1239-48. PubMed ID: 20727946
[TBL] [Abstract][Full Text] [Related]
25. Liraglutide prevents metabolic side-effects and improves recognition and working memory during antipsychotic treatment in rats.
Babic I; Gorak A; Engel M; Sellers D; Else P; Osborne AL; Pai N; Huang XF; Nealon J; Weston-Green K
J Psychopharmacol; 2018 May; 32(5):578-590. PubMed ID: 29493378
[TBL] [Abstract][Full Text] [Related]
26. GLP-1 Analog Alleviated Cognitive Dysfunction in Aged Rats Anaesthetized with Sevoflurane.
Zhang Q; Jiang Y; Zhang Y; Zhang J; Hu Y
Biomed Res Int; 2022; 2022():9339824. PubMed ID: 35615010
[TBL] [Abstract][Full Text] [Related]
27. Glucagon-like peptide-1 (GLP-1) receptor agonist prevents development of tolerance to anti-anxiety effect of ethanol and withdrawal-induced anxiety in rats.
Sharma AN; Pise A; Sharma JN; Shukla P
Metab Brain Dis; 2015 Jun; 30(3):719-30. PubMed ID: 25380665
[TBL] [Abstract][Full Text] [Related]
28. Liraglutide is neurotrophic and neuroprotective in neuronal cultures and mitigates mild traumatic brain injury in mice.
Li Y; Bader M; Tamargo I; Rubovitch V; Tweedie D; Pick CG; Greig NH
J Neurochem; 2015 Dec; 135(6):1203-1217. PubMed ID: 25982185
[TBL] [Abstract][Full Text] [Related]
29. The neuroprotection of liraglutide on diabetic cognitive deficits is associated with improved hippocampal synapses and inhibited neuronal apoptosis.
Yan W; Pang M; Yu Y; Gou X; Si P; Zhawatibai A; Zhang Y; Zhang M; Guo T; Yi X; Chen L
Life Sci; 2019 Aug; 231():116566. PubMed ID: 31201846
[TBL] [Abstract][Full Text] [Related]
30. The GLP-1 Receptor Agonist Liraglutide Improves Memory Function and Increases Hippocampal CA1 Neuronal Numbers in a Senescence-Accelerated Mouse Model of Alzheimer's Disease.
Hansen HH; Fabricius K; Barkholt P; Niehoff ML; Morley JE; Jelsing J; Pyke C; Knudsen LB; Farr SA; Vrang N
J Alzheimers Dis; 2015; 46(4):877-88. PubMed ID: 25869785
[TBL] [Abstract][Full Text] [Related]
31. Liraglutide prevents cognitive decline in a rat model of streptozotocin-induced diabetes independently from its peripheral metabolic effects.
Palleria C; Leo A; Andreozzi F; Citraro R; Iannone M; Spiga R; Sesti G; Constanti A; De Sarro G; Arturi F; Russo E
Behav Brain Res; 2017 Mar; 321():157-169. PubMed ID: 28062257
[TBL] [Abstract][Full Text] [Related]
32. Improvement of cognitive function, glucose and lipid homeostasis and serum osteocalcin levels by liraglutide in diabetic rats.
Sedky AA
Fundam Clin Pharmacol; 2021 Dec; 35(6):989-1003. PubMed ID: 33683755
[TBL] [Abstract][Full Text] [Related]
33. Comparative Study of the Effect of Liraglutide and Donepezil on Learning and Memory in Diazepam-Induced Amnesic Albino Rats.
Kumari K; Kumar S; Sinha RK; Toppo MS
Cureus; 2023 Jul; 15(7):e41495. PubMed ID: 37551235
[TBL] [Abstract][Full Text] [Related]
34. GLP-1R Agonist Liraglutide Attenuates Inflammatory Reaction and Neuronal Apoptosis and Reduces Early Brain Injury After Subarachnoid Hemorrhage in Rats.
Tu XK; Chen Q; Chen S; Huang B; Ren BG; Shi SS
Inflammation; 2021 Feb; 44(1):397-406. PubMed ID: 32951103
[TBL] [Abstract][Full Text] [Related]
35. Prevention of pentylenetetrazole-induced kindling and behavioral comorbidities in mice by levetiracetam combined with the GLP-1 agonist liraglutide: Involvement of brain antioxidant and BDNF upregulating properties.
de Souza AG; Chaves Filho AJM; Souza Oliveira JV; de Souza DAA; Lopes IS; de Carvalho MAJ; de Lima KA; Florenço Sousa FC; Mendes Vasconcelos SM; Macedo D; de França Fonteles MM
Biomed Pharmacother; 2019 Jan; 109():429-439. PubMed ID: 30399578
[TBL] [Abstract][Full Text] [Related]
36. Pharmacokinetics of α-Pyrrolidinovalerophenone in Male Rats with and without Vaccination with an α-Pyrrolidinovalerophenone Vaccine.
McClenahan S; Gunnell M; Owens M
J Pharm Pharm Sci; 2021; 24():267-276. PubMed ID: 34062113
[TBL] [Abstract][Full Text] [Related]
37. Neurobehavioral effects of liraglutide and sitagliptin in experimental models.
Kamble M; Gupta R; Rehan HS; Gupta LK
Eur J Pharmacol; 2016 Mar; 774():64-70. PubMed ID: 26849938
[TBL] [Abstract][Full Text] [Related]
38. Liraglutide Improves Water Maze Learning and Memory Performance While Reduces Hyperphosphorylation of Tau and Neurofilaments in APP/PS1/Tau Triple Transgenic Mice.
Chen S; Sun J; Zhao G; Guo A; Chen Y; Fu R; Deng Y
Neurochem Res; 2017 Aug; 42(8):2326-2335. PubMed ID: 28382596
[TBL] [Abstract][Full Text] [Related]
39. Four weeks administration of Liraglutide improves memory and learning as well as glycaemic control in mice with high fat dietary-induced obesity and insulin resistance.
Porter DW; Kerr BD; Flatt PR; Holscher C; Gault VA
Diabetes Obes Metab; 2010 Oct; 12(10):891-9. PubMed ID: 20920042
[TBL] [Abstract][Full Text] [Related]
40. Characterization of liraglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist, in rat partial and full nigral 6-hydroxydopamine lesion models of Parkinson's disease.
Hansen HH; Fabricius K; Barkholt P; Mikkelsen JD; Jelsing J; Pyke C; Knudsen LB; Vrang N
Brain Res; 2016 Sep; 1646():354-365. PubMed ID: 27233809
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
